Commonwealth Equity Services, LLC Dbv Technologies S.A. Transaction History

Commonwealth Equity Services, LLC

  • $60.2 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024
BUY
$0.7 - $1.33 $824 - $1,566
1,178 Added 7.05%
17,878 $17,000
Q2 2023

Aug 10, 2023
BUY
$1.42 - $2.23 $1,420 - $2,230
1,000 Added 6.37%
16,700 $32,000
Q1 2023

May 11, 2023
BUY
$1.28 - $1.73 $1,280 - $1,730
1,000 Added 6.8%
15,700 $26,000
Q3 2022

Nov 14, 2022
BUY
$1.77 - $2.76 $26,019 - $40,572
14,700 New
14,700 $26,000

Others Institutions Holding DBVT

# of Institutions
32
Shares Held
37.7M
Call Options Held
0
Put Options Held
0
View Full List

About DBV Technologies S.A.

DBVT Quotes by TradingView
  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $175M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email